Aggregated low density lipoprotein induces tissue factor by inhibiting sphingomyelinase activity in human vascular smooth muscle cells
Version of Record online: 8 OCT 2009
© 2009 International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Volume 7, Issue 12, pages 2137–2146, December 2009
How to Cite
CAMINO-LÓPEZ, S., BADIMON, L., GONZÁLEZ, A., CANALS, D., PEÑA, E. and LLORENTE-CORTÉS, V. (2009), Aggregated low density lipoprotein induces tissue factor by inhibiting sphingomyelinase activity in human vascular smooth muscle cells. Journal of Thrombosis and Haemostasis, 7: 2137–2146. doi: 10.1111/j.1538-7836.2009.03638.x
- Issue online: 23 NOV 2009
- Version of Record online: 8 OCT 2009
- Received 2 May 2009, accepted 20 September 2009
- 1Tissue factor and hemostasis. Blood 1988; 71: 1–8..
- 2Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 1990; 82: II47–59., , , , , .
- 3Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594–9., , , , , , , , , , .
- 4Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998; 139: 205–22., , , .
- 5Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. J Lipid Res 1991; 32: 953–62., , .
- 6Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 2004; 110: 452–9., , , , .
- 7Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells. Cardiovasc Res 2007; 73: 208–16., , , .
- 8Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1607–15., , .
- 9Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 1996; 98: 1455–64., , , , , .
- 10Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem 1998; 273: 9681–7., , , .
- 11Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J Biol Chem 2003; 278: 32921–8., , , , .
- 12Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest 1998; 101: 905–12., , , , , .
- 13Niemann-Pick type II fibroblasts exhibit impaired cholesterol esterification in response to sphingomyelin hydrolysis. Biochim Biophys Acta 1992; 1138: 20–6., , , , .
- 14Sphingomyelinases: enzymology and membrane activity. FEBS Lett 2002; 531: 38–46., .
- 15Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase. Mol Biol Cell 2008; 19: 509–22., , , , .
- 16CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 2001; 276: 20589–96., , , , , , , .
- 17Compartmentalized production of ceramide at the cell surface. J Biol Chem 1995; 270: 27179–85., .
- 18Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J Biol Chem 1997; 272: 10922–7., , .
- 19A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J 2001; 355: 859–68., , , , , .
- 20Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2006; 26: 117–23., , , , .
- 21Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol 2002; 22: 387–93., , , , .
- 22Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism. Circulation 2002; 106: 3104–10., , , , .
- 23Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide. J Natl Cancer Inst 2004; 96: 1288–99., , , , , , , , .
- 24Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal Biochem 2002; 302: 191–8., , , .
- 25Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol 1996; 6: 218–23., , .
- 26Distinct mechanisms of clathrin-independent endocytosis have unique sphingolipid requirements. Mol Biol Cell 2006; 17: 3197–210., , , , , , .
- 27Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc Natl Acad Sci USA 2000; 97: 5895–900., , , .
- 28The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc Natl Acad Sci U S A 1966; 55: 366–9., , , .
- 29Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease. Mol Cell Biol 2002; 22: 3633–8., .
- 30Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J Exp Med 2005; 202: 249–59., , , , , , , , , , , .
- 31Reversible topological organization within a polytopic membrane protein is governed by a change in membrane phospholipid composition. J Biol Chem 2003; 278: 50128–35., , , , .
- 32Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest 1997; 100: 2276–85., , , , , , , , , .
- 33Phosphorylation of LRP1: regulation of transport and signal transduction. Trends Cardiovasc Med 2002; 12: 160–5..
- 34Regulation of the composition of the extracellular matrix by low density lipoprotein receptor-related protein-1: activities based on regulation of mRNA expression. J Biol Chem 2006; 281: 7332–40., , , .
- 35Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation. J Neuroimmunol 2009; 214: 25–32., , , .
- 36The JNKs differentially regulate RNA polymerase III transcription by coordinately modulating the expression of all TFIIIB subunits. Proc Natl Acad Sci U S A 2009; 106: 12682–7., .
- 37Signaling pathways involved in glucocorticoid-induced apoptosis of thymocytes. Crit Rev Immunol 2005; 25: 263–88., , .
- 38Mitochondrial ceramide and the induction of apoptosis. J Bioenerg Biomembr 2005; 37: 143–53..
- 39Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. FASEB J 2001; 15: 807–14., , , , , , , , .
- 40Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries. Eur J Clin Invest 2004; 34: 182–90., , , .